SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280600-21-000038
Filing Date
2021-05-06
Accepted
2021-05-06 16:08:51
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xlrn-20210331.htm   iXBRL 10-Q 907500
2 EX-31.1 xlrn-20210331xexhibit311.htm EX-31.1 13617
3 EX-31.2 xlrn-20210331xexhibit312.htm EX-31.2 13680
4 EX-32.1 xlrn-20210331xexhibit321.htm EX-32.1 7274
  Complete submission text file 0001280600-21-000038.txt   4499097

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20210331.xsd EX-101.SCH 34803
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20210331_cal.xml EX-101.CAL 61779
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20210331_def.xml EX-101.DEF 148862
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20210331_lab.xml EX-101.LAB 429481
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20210331_pre.xml EX-101.PRE 263358
10 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20210331_htm.xml XML 702421
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36065 | Film No.: 21897788
SIC: 2836 Biological Products, (No Diagnostic Substances)